Review highlights advances in cancer therapeutics, revealing improved patient outcomes while addressing challenges like drug resistance and immune evasion.
Key Points
Improved patient outcomes in cancer care are evident as advancements in therapeutics have progressed over the decades.
Targeted therapies and immunotherapies, such as immune checkpoint inhibitors, have marked a turning point in treatment efficacy.
Analysis of historical and current cancer therapies illustrates the shift from traditional methods to personalized medicine strategies.
Integration of novel technologies like liquid biopsy and nanomedicine promises enhanced cancer detection and reduced treatment toxicity.